Key Dates
6 May 2008
Notification of Acceptances
26 May 2008
Early Registration Cut-off Date
9 June 2008
Late breaking Abstract Submission Date
2 July 2008
Pre & Post Congress Tours
2 July 2008
Social Program Bookings
2 July 2008
Congress Day Tours
9 July 2008
Accommodation Bookings
9 July 2008
Accommodation Deposit deadline
9-10 August 2008
Postgraduate Weekend Courses
10-14 August 2008
Congress Opens
Dr Jay A. Fishman
Jay A. Fishman is Director of the Transplant Infectious Diseases and Compromised Host Program at the Massachusetts General Hospital (MGH), Associate Director of the MGH Transplant Center, and Associate Professor of Medicine at Harvard Medical School in Boston, Massachusetts, USA. Dr. Fishman is an internationally recognized expert in infectious diseases related to transplantation and has trained many of the leaders in this field. He has a special interest in molecular diagnostics, transplant virology and mycology, and in medical education. He has served on the Boards of the TTS Transplant Infectious Disease and International Xenotransplanation Sections, is Past-President of the American Society of Transplantation, and is a frequent contributor at international symposia. Dr. Fishman's clinical and research interests focus on the pathogenesis and prevention of infection in the immunocompromised host. His laboratory is investigating infectious disease issues related to xenotransplantation and the role of viral infections in transplantation. Dr. Fishman lives with his wife Gayle and two sons Aaron and Brian, in Wellesley, Massachusetts.
Dr. Camille Nelson Kotton
Dr. Camille Nelson Kotton is the clinical director of the Transplant Infectious Disease and Compromised Host Program at the Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. She also directs the outpatient Transplant Infectious Disease Clinic.
She graduated from the University of Chicago School of Medicine, and did her internal medicine training at The Hospital of the University of Pennsylvania followed by an infectious diseases fellowship at the Massachusetts General Hospital and Brigham and Women's Hospital.
Her clinical interests include donor-derived infections, zoonoses, and travel and tropical medicine in the transplant setting. Her research interests center primarily on vaccines, involving both immunocompromised hosts, as well live bacterial vectors in normal hosts. She has served on advisory boards involving issues in transplant infectious diseases. Dr. Kotton is the current president of The Transplant Infectious Disease section of The Transplantation Society.
Dr Kieren Marr
Kieren A. Marr, MD
Professor of Medicine, Division of Infectious Diseases
Director, Transplant Infectious Disease Program
Director, Infectious Diseases Clinical Research Center
Oregon Health and Science University
Portland, Oregon.
Kieren A. Marr received a medical degree from Hahnemann University School of Medicine in Philadelphia, Pennsylvania. Her advanced training included an internship and residency in internal medicine at Duke University School of Medicine (where she served as Assistant Chief Resident) and a fellowship in infectious diseases at the University of Washington and Fred Hutchinson Cancer Research Center in Seattle, Washington.
She was faculty at UW / FHCRC for ten years prior to moving to Oregon Health and Science University, where she currently directs the Program in Tranpslant ID and the ID Clinical Research Center. In addition, Dr. Marr serves as Affiliate Investigator in the Clinical Research Division at the Fred Hutchinson Cancer Research Center (FHCRC). Board certified in internal medicine and infectious diseases, Dr. Marr holds membership in the Infectious Disease Society of America, International Society for Human and Animal Mycology, American Society of Transplantation, and several other professional societies.
Additionally, Dr. Marr serves on several committees and advisory bodies, including the Steering Committee for the Centers for Disease Control and Prevention TRANSNET Fungal Infection Surveillance project, and the NIH study section for antimicrobial agent development and resistance. Dr. Marr is well published, with articles in journals that include the New England Journal of Medicine, Blood, and J Immunology. She has written chapters in several books and served as Editor for the book Diagnosis of Fungal Infections and Section Editor for Infectious Diseases (Cohen and Powderly, 3rd edition). Active in research and research training, Dr. Marr has served as the principal investigator for several federally and commercially supported studies. She twice received a National Institutes of Health Clinical Research Loan Repayment Award. Dr. Marr is a highly sought after speaker for national and international CME events.
Return to the State of The Art Program












